Solvay: résultats du troisième trimestre 2026

Solvay reported Q3 2026 results showing a 3.3% organic revenue decline to €1,031 million and EBITDA margin compression to 16.8%, primarily due to Middle East conflict impacts on its Jubail Peroxides facility and weak soda carbonate markets. The company signed a long-term rare earth supply agreement with Viridis and continues discussions with OneIM for a rare earth joint venture. Solvay maintained its dividend at €0.97 per share and revised 2026 guidance to €720-740 million EBITDA and €120-150 million free cash flow, while progressing toward €300 million in structural cost savings.